Aurinia Pharmaceuticals Inc. (AUPH) › Operating IncomeAurinia Pharmaceuticals Inc. (AUPH) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2018: -$55.24M2019: -$90.94M2020: -$104.29M2021: -$180.74M2022: -$111.47M2023: -$91.69M2024: -$4.69M2025: $104.91M$104.91M2018Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$104.91M+2338.4%2024-$4.69M+94.9%2023-$91.69M+17.7%2022-$111.47M+38.3%2021-$180.74M-73.3%2020-$104.29M-14.7%2019-$90.94M-64.6%2018-$55.24M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share